Diverse IgG serum response to novel glycopeptide epitopes detected within immunodominant stretches of Epstein-Barr virus glycoprotein 350/220: diagnostic potential of O-glycopeptide microarrays

Characterization of the Viral O-Glycopeptidome: a Novel Tool of Relevance for Vaccine Design and Serodiagnosis

(2012) E. Clo et al.   JOURNAL OF VIROLOGY

Control of mucin-type O-glycosylation: A classification of the polypeptide GalNAc-transferase gene family

(2011) E. P. Bennett et al.   GLYCOBIOLOGY

Importance of Antibody in Virus Infection and Vaccine-Mediated Protection by a Latency-Deficient Recombinant Murine  -Herpesvirus-68

(2011) M. L. Freeman et al.   JOURNAL OF IMMUNOLOGY

Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention

(2011) J. I. Cohen et al.   Science Translational Medicine

Alternative approaches to antiviral treatments: focusing on glycosylation as a target for antiviral therapy

(2010) Tony Merry et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Evaluation of Four Commercial Systems for the Diagnosis of Epstein-Barr Virus Primary Infections

(2010) Fernando de Ory et al.   Clinical and Vaccine Immunology

A High-ThroughputO-Glycopeptide Discovery Platform for Seromic Profiling

(2010) Ola Blixt et al.   JOURNAL OF PROTEOME RESEARCH

Enzymatic Glycosylation of Peptide Arrays on Gold Surfaces

(2008) Nicolas Laurent et al.   CHEMBIOCHEM